Newsroom

Primary Endpoint Met in the DETECT Endometriosis Imaging Study

Headline Data Presented at the World Congress on Endometriosis

Serac Healthcare Limited and the Nuffield Department of Women’s and Reproductive Health at the University of Oxford announce that the primary endpoint has been met in the “Detecting Endometriosis expressed inTegrins using teChneTium-99m” (DETECT) Phase II imaging study.

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - Positive Feedback on Phase III Trial Design -  

Serac Healthcare Limited today announced positive feedback from its End of Phase II Meeting with the US Food and Drug Administration (FDA) for the development of ^99mTc-maraciclatide as a diagnostic agent for use with single-photon emission computed tomography (SPECT-CT) for the visualisation and diagnosis of superficial peritoneal endometriosis (SPE) in women aged 16 years of age and older.

DETECT abstract accepted at World Congress on Endometriosis 2025

An abstract on the “Detecting Endometriosis integrins using technetium-99m” (DETECT)  imaging study, has been accepted for oral presentation at the prestigious 16^th World Congress on Endometriosis taking place from 21-24 May in Sydney, Australia.

DETECT Endometriosis Imaging Study Presented at EANM’24

Serac Healthcare Limited announces that its clinical partner, the Nuffield Department of Women’s and Reproductive Health at the University of Oxford, gave a presentation on the “Detecting Endometriosis expressed integrins using technetium-99m” (DETECT) imaging study at the European Association of Nuclear Medicine (EANM) annual congress taking place from 19-23 October in Hamburg, Germany

Poster Presented at MICCAI on AI Joint Classification of Images using ⁹⁹ᵐTc-Maraciclatide

A poster was presented today at the annual conference of the Medical Image Computing and Computer Assisted Intervention Society (MICCAI) taking place from 6-10 October in Marrakesh, Morocco. The poster illustrates the latest methodology used in the ongoing research collaboration with King’s College London to develop AI tools to help clinicians read and interpret scans using ^99mTc-maraciclatide.

EANM DETECT Abstract Published and Presentation Details

An abstract on preliminary data from the DETECT “Detecting Endometriosis expressed integrins using technetium-99m” imaging study, has been published ahead of the upcoming congress of the European Association of Nuclear Medicine (EANM).